(PharmaNewsWire.Com, January 20, 2018 ) According to a new report published by Data Bridge Market Research Titled, The Biopsy Devices Market accounted to USD 6.2 billion in 2016 growing at a CAGR of 14.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Also Global Biopsy Devices Market, By Type (Tissue Biopsy (By Product Type (Instruments (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires), Systems (Biopsy Guns, Vacuum Assisted Biopsy Systems)), By Biopsy Type, By Guidance Technology), Liquid Biopsy (By Product Type (CTC, CT DNA), By Application, By Product Type), By Distribution Channel, By End Users, By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Biopsy devices market provides analysis value, volume sales and company share data for the products used in surgical interventions and critical care units. There was an increasing number of deaths in the last decade owing to excess anesthesia dosage with an advent and exposure of anesthesia monitoring and delivery systems healthcare providers are now able to curb the growth of these deaths.
Major market drivers and restraints:
Increasing aging population
Increasing incidence of Cancer
Government Initiatives to better healthcare
Increasing focus on Cancer Diagnostics and early detection
Technological development in liquid biopsy
Government approvals to more products in the last decade
Global Biopsy Devices Market Segmentation:
The Biopsy Devices Market is segmented on the basis of type into tissue biopsy and liquid biopsy. Tissue biopsy still dominates the market in 2016, however the exceptional growth and increasing number of application approvals for liquid biopsy is expected to drive the growth of this market.
The tissue biopsy devices market segment is further segmented on the basis of product type, biopsy type, application, end user and guidance mode. On the basis of product type the market is segmented into instruments and systems. The instrument sub segment is further sub segmented into biopsy needles, guidance systems, biopsy tables and localization wires. While the systems sub segment is further sub segmented into vacuum assisted biopsy systems and biopsy guns.
The liquid biopsy segment is further segmented on the basis of application, product type, type of circulating biomarkers and by end-users. On the basis of product type the market is segmented into reagents and instruments.
On the basis of geography, biopsy devices market report covers data points for 28 countries across multiple The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. Asia Pacific is expected to grow at the highest CAGR of 23.7% in the forecast period 2017 to 2024.
Global Biopsy Devices Competitive Analysis:
The biopsy devices market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biopsy devices market for Global, Europe, North America, Asia Pacific and South America.
Major Market Competitors:
Some of the major players operating in biopsy devices market
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
